{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T04:12:11Z","timestamp":1695528731738},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1S","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Plast Surg"],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>Cutaneous malignant melanoma is notorious for its aggressive behavior and relatively poor outcome compared with other common skin malignancies. Acral lentiginous melanoma (ALM) accounts for at least 50% of melanoma in the Asian population and has a significantly lower survival rate. However, previous studies of the prognostic factors of melanoma-specific survival were all conducted from Western institutions. Here, we performed a retrospective analysis to investigate this issue.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Fifty patients diagnosed as having clinical node-negative cutaneous malignant melanoma who underwent sentinel lymph node (SLN) biopsy at Taipei Veterans General Hospital between January 2007 and December 2018 were enrolled. Patient demographics, tumor characteristics, and lymph node characteristics were evaluated by chart review.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Eighty-two percent of the melanoma in the sample population was ALM. Twelve patients (24.0%) presented at least 1 metastatic sentinel node, and the average number of retrieved SLNs was 3. Of the patients with positive SLNs who proceeded to completion lymph node dissection, only 2 (16.7%) had metastatic nonsentinel nodes (NSNs). The average follow-up time for all patients was 45 months. Recurrence and melanoma-specific death occurred in 21 patients (42.0%) and 15 patients (30.0%), respectively. Melanoma-specific survival was significantly lower in patients with ulcerative lesions (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.005) and more metastatic SLNs (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.036). The overall morbidity rate of completion lymph node dissection was 66.7%.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The presence of ulcerations and number of metastatic SLNs were the most important prognostic factors in this ALM-dominant Asian cohort. Among patients with clinically negative nodes but positive SLNs, less than one-fourth of patients harbored metastatic NSNs. Completion lymph node dissection carries a relatively high risk of morbidity; therefore, further research regarding predictors of positive NSNs in the Asian population is necessary.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/sap.0000000000002173","type":"journal-article","created":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T09:06:49Z","timestamp":1576055209000},"page":"S48-S53","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic Factors and Clinical Outcomes of Clinical Node-Negative Cutaneous Malignant Melanoma Patients"],"prefix":"10.1097","volume":"84","author":[{"given":"Yi-Fan","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cherng-Kang","family":"Perng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin-Jung","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20230923","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/00008390-200412000-00016","article-title":"Malignant melanoma in Taiwan: a prognostic study of 181 cases","volume":"14","year":"2004","journal-title":"Melanoma Res"},{"key":"bib2-20230923","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2230.2004.01644.x","article-title":"Clinicopathological features and prognostic factors of cutaneous melanoma among Hong Kong Chinese","volume":"29","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"bib3-20230923","doi-asserted-by":"crossref","first-page":"17","DOI":"10.47102\/annals-acadmedsg.V41N1p17","article-title":"Melanoma: differences between Asian and Caucasian patients","volume":"41","year":"2012","journal-title":"Ann Acad Med Singapore"},{"key":"bib4-20230923","first-page":"427","article-title":"Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986\u20132005","volume":"145","year":"2009","journal-title":"Arch Dermatol"},{"key":"bib6-20230923","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ejso.2016.08.007","article-title":"Sentinel node biopsy in melanoma: current controversies addressed","volume":"43","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"bib7-20230923","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa1310460","article-title":"Final trial report of sentinel-node biopsy versus nodal observation in melanoma","volume":"370","year":"2014","journal-title":"N Engl J Med"},{"key":"bib8-20230923","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1470-2045(16)00141-8","article-title":"Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial","volume":"17","year":"2016","journal-title":"Lancet Oncol"},{"key":"bib9-20230923","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion dissection or observation for sentinel-node metastasis in melanoma","volume":"376","year":"2017","journal-title":"N Engl J Med"},{"key":"bib10-20230923","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/archdermatol.2010.371","article-title":"Prognostic usefulness of sentinel lymph node biopsy for patients who have clinically node negative, localized, primary invasive cutaneous melanoma: a Bayesian analysis using informative published reports","volume":"147","year":"2011","journal-title":"Arch Dermatol"},{"key":"bib11-20230923","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/archsurg.137.3.291","article-title":"Clinical node-negative thick melanoma","volume":"137","year":"2002","journal-title":"Arch Surg"},{"key":"bib12-20230923","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archderm.1980.01640310043015","article-title":"Acral lentiginous melanoma","volume":"116","year":"1980","journal-title":"Arch Dermatol"},{"key":"bib13-20230923","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1001\/archinte.166.17.1907","article-title":"Ethnic differences among patients with cutaneous melanoma","volume":"166","year":"2006","journal-title":"Arch Intern Med"},{"key":"bib14-20230923","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jfma.2013.06.018","article-title":"Prognostic factors for Taiwanese patients with cutaneous melanoma undergoing sentinel lymph node biopsy","volume":"114","year":"2015","journal-title":"J Formos Med Assoc"},{"key":"bib15-20230923","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.suc.2014.07.008","article-title":"Melanoma in non-Caucasian populations","volume":"94","year":"2014","journal-title":"Surg Clin North Am"},{"key":"bib16-20230923","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0190-9622(03)02091-7","article-title":"Advanced presentation of melanoma in African Americans","volume":"50","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"bib17-20230923","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1245\/s10434-018-6647-7","article-title":"Prediction of residual nodal disease at completion dissection following positive sentinel lymph node biopsy for melanoma","volume":"25","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"bib18-20230923","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.amjsurg.2018.01.033","article-title":"Patients with sentinel lymph node positive melanoma: who needs completion lymph node dissection?","volume":"215","year":"2018","journal-title":"Am J Surg"},{"key":"bib19-20230923","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.bjps.2017.05.025","article-title":"Sentinel node biopsy status is strongly predictive of survival in cutaneous melanoma: extended follow-up of Oxford patients from 1998 to 2014","volume":"70","year":"2017","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"bib20-20230923","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1245\/s10434-012-2652-4","article-title":"Evidence for a better nodal staging system for melanoma: the clinical relevance of metastatic disease confined to the sentinel lymph nodes","volume":"20","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"bib21-20230923","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/jamasurg.2013.3044","article-title":"Staging of regional lymph nodes in melanoma: a case for including nonsentinel lymph node positivity in the American Joint Committee on Cancer staging system","volume":"148","year":"2013","journal-title":"JAMA Surg"},{"key":"bib22-20230923","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1245\/s10434-017-6143-5","article-title":"Prediction of non-sentinel node status in patients with melanoma and positive sentinel node biopsy: an Italian Melanoma Intergroup (IMI) study","volume":"25","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"bib23-20230923","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/jso.25193","article-title":"A model for predicting low probability of nonsentinel lymph node positivity in melanoma patients with a single positive sentinel lymph node","volume":"118","year":"2018","journal-title":"J Surg Oncol"},{"key":"bib24-20230923","first-page":"301","article-title":"Prognostic significance of microscopic tumor burden in sentinel lymph node in patients with cutaneous melanoma","volume":"35","year":"2015","journal-title":"Anticancer Res"},{"key":"bib25-20230923","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/bmj.38849.680509.AE","article-title":"Value of sentinel node status as a prognostic factor in melanoma: prospective observational study","volume":"332","year":"2006","journal-title":"BMJ"},{"key":"bib26-20230923","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1200\/JCO.2013.50.7681","article-title":"Nonsentinel lymph node status in patients with cutaneous melanoma: results from a multi-institution prognostic study","volume":"32","year":"2014","journal-title":"J Clin Oncol"},{"key":"bib27-20230923","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ejso.2006.05.003","article-title":"Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma","volume":"32","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"bib28-20230923","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/SLA.0b013e318161312a","article-title":"Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma","volume":"247","year":"2008","journal-title":"Ann Surg"},{"key":"bib29-20230923","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejca.2018.02.022","article-title":"Risk stratification of sentinel node\u2013positive melanoma patients defines surgical management and adjuvant therapy treatment considerations","volume":"96","year":"2018","journal-title":"Eur J Cancer"},{"key":"bib30-20230923","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.surg.2015.12.002","article-title":"Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes","volume":"159","year":"2016","journal-title":"Surgery"},{"key":"bib31-20230923","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","article-title":"Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system","volume":"19","year":"2001","journal-title":"J Clin Oncol"},{"key":"bib32-20230923","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/CMR.0000000000000164","article-title":"Tumor-infiltrating lymphocytes predict cutaneous melanoma survival","volume":"25","year":"2015","journal-title":"Melanoma Res"}],"container-title":["Annals of Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SAP.0000000000002173","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T05:05:44Z","timestamp":1695445544000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SAP.0000000000002173"}},"subtitle":["An Asian Single Institute Study"],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":31,"journal-issue":{"issue":"1S","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/sap.0000000000002173","relation":{},"ISSN":["1536-3708","0148-7043"],"issn-type":[{"value":"1536-3708","type":"electronic"},{"value":"0148-7043","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}